Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

[1]  Zhiwen Liu,et al.  Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis , 2012, Diabetes/metabolism research and reviews.

[2]  F. Sung,et al.  Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study , 2012, The American Journal of Gastroenterology.

[3]  S. Mousa,et al.  Metformin and neoplasia: implications and indications. , 2012, Pharmacology & therapeutics.

[4]  E. Vicaut,et al.  Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  G. Gores,et al.  Strategies for hepatocellular carcinoma therapy and diagnostics: Lessons learned from high throughput and profiling approaches , 2011, Hepatology.

[6]  J. Ertle,et al.  Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis , 2011, International journal of cancer.

[7]  D. Leroith,et al.  Minireview: IGF, Insulin, and Cancer. , 2011, Endocrinology.

[8]  Chun-Che Lin,et al.  Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation , 2011, Journal of gastroenterology and hepatology.

[9]  T. Saibara,et al.  Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[11]  E. Mita,et al.  Hepatocellular carcinomas can develop in simple fatty livers in the setting of oxidative stress. , 2011, Pathology.

[12]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[13]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[14]  C. Dejong,et al.  Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[15]  A. Sanyal,et al.  Population-based risk factors and resource utilization for HCC: US perspective , 2010, Current medical research and opinion.

[16]  C. Hellerbrand,et al.  Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications , 2010, Gut.

[17]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[18]  Rocio Lopez,et al.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.

[19]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[20]  G. Zanette,et al.  Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[21]  Manal M. Hassan,et al.  Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma , 2010, Cancer.

[22]  K. Nouso,et al.  Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. , 2010, World journal of gastroenterology.

[23]  L. Orci,et al.  Lipid homeostasis, lipotoxicity and the metabolic syndrome. , 2010, Biochimica et biophysica acta.

[24]  A. Kimmel,et al.  Adoption of PERILIPIN as a unifying nomenclature for the mammalian PAT-family of intracellular lipid storage droplet proteins , 2010, Journal of Lipid Research.

[25]  J. Bruix,et al.  Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.

[26]  Greger Lindberg,et al.  Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up , 2010, Hepatology.

[27]  M. Torbenson,et al.  Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers , 2010, Modern Pathology.

[28]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[29]  A. Warth,et al.  Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis , 2010, Modern Pathology.

[30]  V. Alves,et al.  Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients? , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[31]  F. Marra,et al.  Adipokines in liver diseases , 2009, Hepatology.

[32]  K. Imanaka,et al.  Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis , 2009, Journal of Gastroenterology.

[33]  K. Sjögren,et al.  The role of liver-derived insulin-like growth factor-I. , 2009, Endocrine reviews.

[34]  P. Chou,et al.  The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses , 2009, Cancer Epidemiology Biomarkers & Prevention.

[35]  M. Vinciguerra,et al.  Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. , 2009, Journal of hepatology.

[36]  N. Bardeesy,et al.  Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. , 2009, Biochemical and biophysical research communications.

[37]  Christopher D Byrne,et al.  Metabolic disturbances in non-alcoholic fatty liver disease. , 2009, Clinical science.

[38]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  V. Paradis,et al.  Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.

[40]  Chunhong Bai,et al.  Long-term follow-up of patients with nonalcoholic fatty liver. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  Katsutoshi Tokushige,et al.  Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C , 2009, Journal of gastroenterology and hepatology.

[42]  M. Honda,et al.  Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. , 2009, Journal of hepatology.

[43]  M. Taniai,et al.  Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2009, Journal of Gastroenterology.

[44]  G. Chejfec,et al.  Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? , 2008, Archives of pathology & laboratory medicine.

[45]  Jeanne M Clark,et al.  The epidemiology of nonalcoholic fatty liver disease: a global perspective. , 2008, Seminars in liver disease.

[46]  Chien-Jen Chen,et al.  Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. , 2008, Gastroenterology.

[47]  M. Manns,et al.  Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus , 2008, Hepatology.

[48]  Michael Charlton,et al.  Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain? , 2008, Hepatology.

[49]  Neil D Theise,et al.  Hepatic precancerous lesions and small hepatocellular carcinoma. , 2007, Gastroenterology clinics of North America.

[50]  A. Diehl,et al.  Nonalcoholic fatty liver disease as a complication of insulin resistance. , 2007, The Medical clinics of North America.

[51]  M. Mori,et al.  Primary liver cancers with nonalcoholic steatohepatitis , 2007, European journal of gastroenterology & hepatology.

[52]  J. Menéndez,et al.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.

[53]  C. McClain,et al.  Palmitic acid induces production of proinflammatory cytokine interleukin‐8 from hepatocytes , 2007, Hepatology.

[54]  S. Larsson,et al.  Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies , 2007, British Journal of Cancer.

[55]  J. Pekow,et al.  Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis , 2007, Cancer.

[56]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[57]  Y. Takei,et al.  Role of adipocytokines in hepatic fibrogenesis , 2007, Journal of gastroenterology and hepatology.

[58]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[59]  T. Murakami,et al.  Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. , 2007, Radiology.

[60]  C. Harris,et al.  TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer , 2007, Oncogene.

[61]  E. Bugianesi,et al.  Non-alcoholic steatohepatitis and cancer. , 2007, Clinics in liver disease.

[62]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[63]  K. Eguchi,et al.  Two cases of non‐alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis , 2006, Journal of gastroenterology and hepatology.

[64]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[65]  Ronald A. DePinho,et al.  Hepatocellular carcinoma pathogenesis: from genes to environment , 2006, Nature Reviews Cancer.

[66]  Dong Wang,et al.  Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[67]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[68]  P. Schirmacher,et al.  Dysregulation of growth factor signaling in human hepatocellular carcinoma , 2006, Oncogene.

[69]  V. Thakur,et al.  Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[70]  G. Gores,et al.  Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis* , 2006, Journal of Biological Chemistry.

[71]  Robert A Fisher,et al.  Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.

[72]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[73]  C. Kahn,et al.  From mice to men: insights into the insulin resistance syndromes. , 2006, Annual review of physiology.

[74]  S. Milani,et al.  Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells , 2005, Hepatology.

[75]  S. Terai,et al.  Leptin enhances TNF-α production via p38 and JNK MAPK in LPS-stimulated Kupffer cells , 2005 .

[76]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[77]  R O Morgan,et al.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study , 2005, Gut.

[78]  J. Crespo,et al.  Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma , 2005, Obesity surgery.

[79]  S. Terai,et al.  Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells. , 2005, Life sciences.

[80]  K. Wakasa,et al.  Hepatocellular Carcinoma Arising from Nonalcoholic Steatohepatitis: Report of Two Cases , 2005, Surgery Today.

[81]  H. Tilg,et al.  Adiponectin and its receptors in non-alcoholic steatohepatitis , 2004, Gut.

[82]  M. Jensen,et al.  Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. , 2004, Journal of hepatology.

[83]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[84]  B. le Bail,et al.  Obesity as a Risk Factor for Hepatocellular Carcinoma in a Noncirrhotic Patient , 2004, Seminars in liver disease.

[85]  D. Lobo,et al.  Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. , 2004, Journal of hepatology.

[86]  A. Luciani,et al.  Carcinome hépatocellulaire en l’absence de cirrhose au cours d’une stéato-hépatite non alcoolique , 2004 .

[87]  H. Kitano.  Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.

[88]  S. Kihara,et al.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[89]  H. El‐Serag,et al.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.

[90]  E. Abdalla,et al.  Obesity and diabetes as a risk factor for hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[91]  A. Luciani,et al.  [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis]. , 2004, Gastroenterologie clinique et biologique.

[92]  Hyeon Joo Lee,et al.  Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. , 2003, The American journal of pathology.

[93]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[94]  J. Marrero,et al.  NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.

[95]  Lu-Yu Hwang,et al.  Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.

[96]  Harri Vainio,et al.  Overweight, obesity, and cancer risk. , 2002, The Lancet. Oncology.

[97]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[98]  G. Loss,et al.  Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? , 2002, Hepatology.

[99]  Mauro Salizzoni,et al.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. , 2002, Gastroenterology.

[100]  B. Carr,et al.  Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents. , 2002, Radiology.

[101]  P. Bioulac-Sage,et al.  [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[102]  S. Hirohashi,et al.  Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma , 2000, Hepatology.

[103]  P. Thuluvath,et al.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.

[104]  P. Pineau,et al.  Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases , 2000, Hepatology.

[105]  G. Marchesini,et al.  Association of nonalcoholic fatty liver disease with insulin resistance. , 1999, The American journal of medicine.

[106]  S. Caldwell,et al.  Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.

[107]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[108]  V. Paradis,et al.  Clonal analysis of macronodules in cirrhosis , 1998, Hepatology.

[109]  C. la Vecchia,et al.  Attributable risks for hepatocellular carcinoma in northern Italy. , 1997, European journal of cancer.

[110]  C. la Vecchia,et al.  Diabetes mellitus and the risk of primary liver cancer. , 1997, International journal of cancer.

[111]  K. Ishak,et al.  Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. , 1996, American journal of clinical pathology.

[112]  M. Colombo,et al.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[113]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[114]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.